The Conversation: No, vaccinated people are not ‘just as infectious’ as unvaccinated people if they get COVID
Recent studies have shown similar peak viral loads in vaccinated people who contract COVID-19 disease compared with unvaccinated people who contract COVID, raising questions around the impact that vaccination has on preventing transmission.
This article discusses the findings from recent studies on viral load and further explores the impact that vaccination has on those who experience breakthrough disease. It specifically highlights how vaccinated individuals with breakthrough disease can clear the virus faster, have lower levels of the virus overall, and therefore are less contagious.
要阅读全文，请点击以下链接：
The Conversation: No, vaccinated people are not ‘just as infectious’ as unvaccinated people if they get COVID
Last chance to register for day 2 of our Clinical Vaccinology Update (CVU)
There's still time to register for the final day of our Clinical Vaccinology Update (CVU) and hear from leading experts addressing the most important issues in immunisation.
Tomorrow we're excited to be hosting a panel session with Professor Julie Leask, Dr Preeya Alexander and A/Prof Nigel Crawford on mandatory vaccination and no fault compensation!
To register for the event, please click on the link below:
MVEC Clinical Vaccinology Update (CVU) 2021
New Kids Health Info Podcast Episode - Fear of needles. What helps?
A new episode of the popular Kids Health Info podcast on the Fear of needles is now available.
In this session, the hosts are joined by two special guests - Sonja Elia, an Immunisation Nurse Practitioner and head of the RCH Immunisation Drop-In Centre, and Dr Amanda Stock, a Paediatrician and Emergency Physician from the RCH where they discuss helpful strategies and techniques available to children and families to manage anxiety about needles.
To listen to the podcast, please click on the link below:
Kids Health Info podcast: Fear of needs. What helps?
Healthed Going Viral Podcast featuring A/Prof Nigel Crawford
MVEC’s Associate Professor Nigel Crawford delivered the COVID-19 Update as part of the recent Healthed Australia online lecture series.
In this lecture, A/Prof Nigel Crawford discussed the following:
- COVID booster dose
- Myocarditis following mRNA vaccine
- Vaccinating 5-11-year-olds with Pfizer
- Best vaccine delivery method
- Opening the borders – don’t forget there are many vaccine-preventable diseases (VPDs)
To listen to the lecture in full, click on the link below:
Healthed lecture series 11 November: COVID-19 Update
The Conversation: Nose sprays, needle-free patches, durable immunity: towards the next generation of COVID vaccination
The COVID-19 pandemic has perpetuated rapid medical advancements and technological innovations. Over the last 20 months, we’ve experienced an influx of new vaccines which have proven to be safe and effective in preventing disease.
Scientists and researchers around the world are already working on the next generation of COVID vaccines to help tackle issues regarding waning immunity, storage and delivery, and vaccine hesitancy. Focusing their efforts on making vaccination easier, delivering more durable immunity and protecting against future variants
This article looks at the different considerations for research and technology around the world that will in turn lead to the next generation of COVID vaccines.
Follow the link to read the full article: Nose sprays, needle-free patches, durable immunity: towards the next generation of COVID vaccination
There's still time to register for the Clinical Vaccinology Update (CVU) 2021!
There's still time to register for the Clinical Vaccinology Update (CVU) 2021 taking place virtually on Thursday 18th and Friday 19th November.
This 2-day virtual program will allow participants to choose from keynote sessions delivered on our virtual main stage in addition to themed seminars and interactive workshops hosted by industry experts, addressing the most important issues in immunisation.
To find out more about the program and to register, please click on the link below to our Events page:
MVEC: Clinical Vaccinology Update (CVU) 2021
Moderna's COVID-19 vaccine (SPIKEVAX) - provisional determination granted for proposed use in children and booster shot for adults under evaluation
The Therapeutic Goods Administration (TGA) has granted provisional determination to Moderna Australia Pty Ltd in relation to its COVID-19 vaccine, SPIKEVAX.
SPIKEVAX is provisionally approved for use in individuals 12 years of age or older. The granting of this determination means that Moderna Australia Pty Ltd is eligible to apply to vary the provisional approval for the vaccine for use in younger children.
要阅读更多信息，请点击以下链接：
Moderna's COVID-19 vaccine (SPIKEVAX) - provisional determination granted for proposed use in children and booster shot for adults under evaluation
New immunisation reference page: COVID-19 vaccine compensation scheme
The No Fault COVID-19 Indemnity Scheme is a Commonwealth government funded initiative that has been introduced to allow Australians who have been significantly impacted by an adverse event following a COVID-19 vaccine to apply for financial assistance.
Our new reference page outlines the No Fault COVID-19 Indemnity Scheme, including which vaccines are covered under the scheme, and how to make a claim.
要了解更多信息，请点击以下链接：
MVEC: COVID-19 vaccine compensation scheme
Reminder to register for the Clinical Vaccinology Update (CVU) 2021!
A reminder to register for the Clinical Vaccinology Update (CVU) 2021 taking place virtually on Thursday 18th and Friday 19th November.
This 2-day virtual program will allow participants to choose from keynote sessions delivered on our virtual main stage in addition to themed seminars and interactive workshops hosted by industry experts, addressing the most important issues in immunisation.
To find out more about the program and to register, please click on the link below to our Events page:
MVEC: Clinical Vaccinology Update (CVU) 2021
The Conversation: COVID vaccines for 5 to 11 year old’s are inching closer. Here’s what we know so far
This week, the US Food and Drug Administration (FDA) has authorised the provisional use of the Pfizer COVID-19 vaccine in children between the age of 5 to 11 years. Children will receive two doses of the vaccine, at a reduced dose (one-third of the adult dose) administered approximately three weeks apart.
Pfizer has submitted a partial application to Australia’s Therapeutic Goods Administration (TGA) and is currently on track to supply the remaining data over the next two weeks. Once approved, the Australian Technical Advisory Group on Immunisations (ATAGI) will advise the government on timing the rollout.
Current data suggests a clear advantage to immunising children against COVID-19, including protecting them from severe complications associated with the Delta variant, and helping to minimise the spread of the virus amongst the more vulnerable in the community.
Follow this link to read the full article:
COVID vaccines for 5 to 11 year old’s are inching closer. Here’s what we know so far